Grey Wolf Animal Health Corp

Grey Wolf Animal Health Corp maintains a capital structure with a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity position is characterized by a current ratio of 3.17, suggesting strong short-term liquidity. However, the operating cash flow is negative at -1,812,690 CAD, which may raise concerns about the company's ability to sustain operations without external financing. In terms of profitability, the company's return on equity (ROE) is 0.5%, and return on assets (ROA) is 0.33%, both of which are below the industry median for profitability metrics. The net income of 126,070 CAD and operating income of 291,150 CAD indicate modest profitability, with a gross profit margin of 51.47% (3,112,160 CAD / 6,046,510 CAD revenue). These figures suggest that the company is not outperforming its peers in terms of generating returns on invested capital. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher risks if demand in its primary market fluctuates. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's exposure to different markets or product lines. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The current fiscal year's revenue is 6,046,510 CAD, and there is no indication of a significant increase in the next fiscal year. The company's capital expenditure of -52,820 CAD suggests minimal investment in new projects or expansion, which may limit future growth opportunities. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could necessitate additional financing. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. The valuation adjustments applied in the custom valuations do not indicate significant overvaluation or undervaluation. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments.